Welcome to Esperantomondo News

top
Page
Menu
News

Studnicki medication thiessen pxypyjv167

.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K; KEYNOTE-590 Investigators..
.
.
. Han X, et al. Biomed Pharmacother. 2018 Dec;108:809-816. doi: 10.1016/j.biopha.2018.09.087. Epub 2018 Sep 22. Biomed Pharmacother. 2018. PMID: 30253373

top
top
Page
Menu
News
  • NEW PAGE
Home Print viewSitemap
 
top
Page
Menu
News